M1 Kliniken AG

M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share

M1 Kliniken AG decides to start share buyback

M1 Kliniken AG decides to start share buyback

M1 Kliniken AG disposes subsidiary ‘M1 Aesthetics GmbH’ to HAEMATO AG – Transfer of the holding of the company within the scope of a capital increase in kind of HAEMATO AG

M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG – Group

M1 Kliniken AG: acquires ca. 48 % of the shares of HAEMATO AG – transfer of the shares in a capital increase against contribution in kind of M1 Kliniken AG